SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 34 filers reported holding SCPHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,000 | 0.0% | 357 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | +100.0% | 357 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 357 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 357 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 357 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -50.0% | 357 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | 0.0% | 357 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | 0.0% | 357 | 0.0% | 0.00% | – |
| Q4 2017 | $4,000 | – | 357 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,857,143 | $35,429,000 | 2.71% |
| Orbimed Advisors | 3,409,865 | $42,282,000 | 0.52% |
| AWM Investment Company, Inc. | 213,317 | $2,645,000 | 0.51% |
| DAFNA Capital Management LLC | 55,844 | $692,000 | 0.34% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 40,373 | $501,000 | 0.07% |
| Alyeska Investment Group, L.P. | 223,438 | $2,771,000 | 0.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 24,330 | $302,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 69,500 | $862,000 | 0.01% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 36,206 | $449,000 | 0.00% |
| PEDDOCK CAPITAL ADVISORS, LLC | 100 | $1,000 | 0.00% |